Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Generics (U.K.) Ltd. manufactures generic pharmaceutical products. It makes generic drugs which includes acid reflux remedy Pepcid, antibiotic Cipro and allergy treatment Zyrtec. The firm also manufactures cytotoxics such as azathioprine and penicillin based antibiotics. The company was founded on April 29, 1981 and is headquartered in Potters Bar, the United Kingdom.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.

Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.

Qingdao Marine Biomedical Research Institute Co., Ltd., established on 2013-07-26, Business scope includes licensed projects:Drug Wholesale;pharmaceutical production;Drug retail;Pharmaceutical commissioned production;Health food production;Health food sales;food production;food business(Selling prepackaged food);food business(sell bulk food);food business;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Sales of formula food for special medical purposes;Production of formula food for special medical purpose;Cosmetic production;Production of sterile equipment;Disinfection equipment sales;Inspection and testing service;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;New material technology research and development;New material technology promotion service;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products;Cosmetics Wholesale;Cosmetics Retail;Disinfectant sales(Free of Hazardous Chemicals);Extraction of marine bioactive substances,purification,Synthesis technology research and development;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Offshore engineering design and module design and manufacturing services;Asset management services for self-owned capital investment.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.

Medichem SA is a Spanish company located in Sant Joan Despi with domestic subsidiaries. The firm manufactures and supplies pharmaceutical ingredients. It was founded in 1972. José Luis Rodríguez has been the CEO since 1996.

Jiangsu Aosaikang Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical chemicals and health-care products. It offers antibiotics and injections for the digestive, oncology, cardiovascular, and others. The company was founded on January 14, 2003 and is headquartered in Nanjing, China.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Novartis-Erfindungen Verwaltungsgesellschaft m.b.H. specializes in pharmaceutical research and invention. The company is headquartered in Vienna, Austria.

TheraVida, Inc. develops and commercializes therapeutic products that improve the lives of patients. The firm's products help to treatment of overactive bladder and urge urinary incontinence. It develops a portfolio of combination pharmaceutical products in the fields of urology and central nervous system disorders. The company was founded by Mehdi Paborji in 2005 and is headquartered in Chapel Hill, NC.

Beijing Wanquan Sunshine Pharmaceutical Technology Co., Ltd., established on 2000-08-03, Business scope includes research,develop drugs,Natural medicines and chemical synthetic medicines;provide research,develop biopharmaceuticals,Technology transfer of natural medicines and chemical synthetic medicines,Technical Services;Pharmacological clinical research of drugs.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Qingdao Haiji Bio-Pharmaceutical Co., Ltd., established on 2019-07-26, Business scope includes biotechnology,medicine,chemicals,Technology development in the high-tech field,technology transfer,Technical Services,technical consulting,Sales:chemical agent(Free of Hazardous Chemicals),Biological product(In addition to vaccines),Health Supplies,food(Carry out business activities according to the license issued by the Food and Drug Administration),medical instruments(Carry out business activities according to the license issued by the Food and Drug Administration),biology,Chemical instrument technology testing,analyze,testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Bengbu Fengyuan Pharmaceutical Technology Dev Co. Ltd., a subsidiary of Anhui Fengyuan Pharmaceutical Co., Ltd., is a company headquartered in Bengbu, China, that manufactures and distributes pharmaceuticals, food additives and other chemicals. Anhui Fengyuan Pharmaceutical Co., Ltd. acquired Bengbu Fengyuan Pharmaceutical Technology Dev Co. Ltd. from Anhui Fengyuan Group Holding Co., Ltd. on April 30, 2012 for $1.14 million.

Eisai R&D Management Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Bunkyo, Japan. The firm engages in research and development of pharmaceuticals.